Found: 48
Select item for more details and to access through your institution.
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6247, doi. 10.1007/s00432-022-04562-5
- By:
- Publication type:
- Article
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01000-2
- By:
- Publication type:
- Article
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Survey of Patient Experience in CML: American and Canadian Perspectives.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 331, doi. 10.2147/PPA.S394332
- By:
- Publication type:
- Article
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Implementation and evaluation of high-dose methotrexate administration guidelines.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1675, doi. 10.1177/1078155218808866
- By:
- Publication type:
- Article
BCR::ABL1 digital PCR for treatment‐free remission prediction in chronic myeloid leukemia patients: An individual participant data meta‐analysis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1632, doi. 10.1002/ajh.27359
- By:
- Publication type:
- Article
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 606, doi. 10.1002/ajh.27231
- By:
- Publication type:
- Article
Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E232, doi. 10.1002/ajh.26546
- By:
- Publication type:
- Article
Clarifying the Use of Ruxolitinib in Patients With Myelofibrosis.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 706
- By:
- Publication type:
- Article
Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 1, p. e13, doi. 10.1111/j.1365-4632.2011.05350.x
- By:
- Publication type:
- Article
Emerging Safety Issues with Imatinib and Other Abl Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S105
- By:
- Publication type:
- Article
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950
- By:
- Publication type:
- Article
AML with Blast-Negative CNS Involvement.
- Published in:
- Wisconsin Medical Journal, 2011, v. 110, n. 4, p. 201
- By:
- Publication type:
- Article
Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207221150305
- By:
- Publication type:
- Article
Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 8, p. 1036, doi. 10.1007/s11864-023-01105-z
- By:
- Publication type:
- Article
Treatment of metastatic malignant melanoma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 11, p. 2996, doi. 10.1002/cncr.10576
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 333, doi. 10.1016/j.clml.2023.02.008
- By:
- Publication type:
- Article
CML-311: Healthcare Resource Utilization and Associated Costs Among Patients with Chronic Myeloid Leukemia by Line of Therapy in the United States (US) from a Commercial Perspective.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S333, doi. 10.1016/S2152-2650(21)01780-8
- By:
- Publication type:
- Article
Poster: CML-311: Healthcare Resource Utilization and Associated Costs Among Patients with Chronic Myeloid Leukemia by Line of Therapy in the United States (US) from a Commercial Perspective.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01424-5
- By:
- Publication type:
- Article
Update on Treatment-Free Remission in CML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)01246-5
- By:
- Publication type:
- Article
Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S221, doi. 10.1016/j.clml.2018.07.091
- By:
- Publication type:
- Article
Efficacy and Safety Outcomes by Baseline Comorbidity and Age in Patients Newly Diagnosed with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Treated with Dasatinib or Imatinib in DASISION.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S14, doi. 10.1016/j.clml.2017.09.042
- By:
- Publication type:
- Article
Trial in Progress: A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S277, doi. 10.1016/j.clml.2017.07.056
- By:
- Publication type:
- Article
Five-Year Efficacy and Safety of Dasatinib and Imatinib by Baseline Comorbidity and Age in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) from DASISION.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S312, doi. 10.1016/j.clml.2017.07.113
- By:
- Publication type:
- Article
Incidence and Outcomes of Acute Myeloid Leukemia (AML) with Myelodysplasia (MDS) Related Changes in the United States.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S293, doi. 10.1016/j.clml.2017.07.083
- By:
- Publication type:
- Article
A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/6514604
- By:
- Publication type:
- Article
Real-world Management of CML: Outcomes and Treatment Patterns.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 5, p. 167, doi. 10.1007/s11899-023-00703-w
- By:
- Publication type:
- Article
Treatment-Free Remission: the New Goal in CML Therapy.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 5, p. 433, doi. 10.1007/s11899-021-00653-1
- By:
- Publication type:
- Article
Treatment-Free Remission in CML: the US Perspective.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 1, p. 56, doi. 10.1007/s11899-019-0496-8
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 415, doi. 10.1007/s11899-017-0404-z
- By:
- Publication type:
- Article
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E563, doi. 10.1002/ajh.24825
- By:
- Publication type:
- Article
Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 8, p. 579, doi. 10.1002/ajh.21761
- By:
- Publication type:
- Article
Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 43, doi. 10.1186/1756-8722-5-43
- By:
- Publication type:
- Article
Dasatinib dose management for the treatment of chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e744, doi. 10.1634/theoncologist.2019-0890
- By:
- Publication type:
- Article
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1253, doi. 10.1634/theoncologist.2018-0831
- By:
- Publication type:
- Article
Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
- Published in:
- Acta Haematologica, 2018, v. 139, n. 3, p. 171, doi. 10.1159/000487879
- By:
- Publication type:
- Article
Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 6, p. 934, doi. 10.1002/cncr.34604
- By:
- Publication type:
- Article
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol.
- Published in:
- EJHaem, 2024, v. 5, n. 5, p. 951, doi. 10.1002/jha2.991
- By:
- Publication type:
- Article
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 2, p. 80, doi. 10.1007/s11899-016-0306-5
- By:
- Publication type:
- Article
Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT).
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 1, p. 57, doi. 10.1007/s11899-013-0195-9
- By:
- Publication type:
- Article